Pancreatic adenocarcinoma

New England Journal of Medicine

Volumn 371, Issue 22, 2014, Pages 2139-2141

  Bükki, Johannes ^a  

^a Hospice Care DaSein   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER PAIN; CANCER SURVIVAL; CLINICAL FEATURE; HUMAN; LETTER; PALLIATIVE THERAPY; PANCREAS ADENOCARCINOMA; QUALITY OF LIFE; SYMPTOM; ADENOCARCINOMA; PANCREAS TUMOR;

ADENOCARCINOMA; HUMANS; PANCREATIC NEOPLASMS;

EID: 84922010726     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1412266     Document Type: Article

References (6)

1. Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med 2014;371:1039-49.
2. Schildmann J, Ritter P, Salloch S, Uhl W, Vollmann J. 'One also needs a bit of trust in the doctor . . . ': a qualitative interview study with pancreatic cancer patients about their perceptions and views on information and treatment decision-making. Ann Oncol 2013;24:2444-9.
3. Burris HA III, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997;15:2403-13.
4. Bernhard J, Dietrich D, Glimelius B, Bodoky G, Scheithauer W, Herrmann R. Clinical benefit response in pancreatic cancer trials revisited. Oncol Res Treat 2014;37:42-8.
5. Herrmann R, Bodoky G, Ruhstaller T, et al. Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group. J Clin Oncol 2007;25: 2212-7.
6. Good P, Cavenagh J, Mather M, Ravenscroft P. Medically assisted nutrition for palliative care in adult patients. Cochrane Database Syst Rev 2008;4:CD006274.